Could cause temporary or reversible harm; serious harm is unlikely.
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
| Brand name | GABAPENTIN |
| Generic name | GABAPENTIN |
| Active ingredient(s) | GABAPENTIN |
| Distributed by / for | Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA |
| NDC | 14550-513-02 |
| Full product label | Gabapentin Capsules, USP, 400 mg, Rx Only, a) 100 capsules per bottle, NDC 14550-513-02, b) 500 Capsules per bottle, NDC 45963-557-50, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA. |
| Recalling firm | Actavis Elizabeth LLC |
| Distribution | Puerto Rico |
| Quantity | 10,857 Bottles |
| Recall initiated | 2014-12-15 |
| Report date | 2015-01-14 |
| Recall completed | 2015-11-20 |
| Recall number | D-0336-2015 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Elizabeth NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗